City

Basel (2)

Groningen (1)

Tampa (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Terminated (1)

Phase

early phase 1 (1)

n/a (1)

phase 1 (1)

phase 2 (1)

Sponsor

University Hospital, Basel, Switzerland (2)

H. Lee Moffitt Cancer Center and Research Institute (1)

University Medical Center Groningen (1)

Collaborator

Center for Proton Therapy, Paul Scherrer Institute, Villigen,Switzerland (2)

Krebsforschung Schweiz, Bern, Switzerland (2)

University Hospital Freiburg (2)

University Hospital, Zurich (2)

Intervention

177lu-pp-f11n (2)

18f-psma-1007 (1)

cabozantinib (1)

lenvatinib (1)

sacuitril (1)

sorafenib (1)

vandetanib (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (4)

Study Type

Interventional (4)

thyroid cancer, medullary

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

Not yet recruiting

Medullary Thyroid Cancer
+3 more

18F-PSMA-1007

Groningen, Netherlands

University Medical Centre Groningen

Sep 8, 2022

Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2

Recruiting

Thyroid Cancer, Medullary
+3 more

177Lu-PP-F11N

Basel, Switzerland

University Hospital Basel, Clinic for radiology and nuclear medi

May 23, 2022

Thyroid Cancer, Medullary Trial in Basel (177Lu-PP-F11N, Sacuitril)

Completed

Thyroid Cancer, Medullary

Basel, Switzerland

University Hospital Basel, Clinic for radiology and nuclear medi

Feb 9, 2022

Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

Terminated

Has Results

Thyroid Cancer
+5 more

Lenvatinib
+3 more

Tampa, Florida

H. Lee Moffitt Cancer Center and Research Institute

Jul 12, 2021